Immediate Impact
2 by Nobel laureates 12 from Science/Nature 67 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
RHOJ controls EMT-associated resistance to chemotherapy
2023 StandoutNature
Works of Allen Li being referenced
Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor
2012
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Allen Li | 285 | 148 | 565 | 172 | 37 | 954 | |
| Yuka Yanagisawa | 315 | 75 | 660 | 213 | 30 | 1.1k | |
| Xuesong Dong | 209 | 198 | 396 | 70 | 39 | 1.0k | |
| Zhiyuan Wu | 229 | 56 | 446 | 52 | 61 | 1.0k | |
| Patricia Kumar | 118 | 61 | 583 | 64 | 35 | 1.1k | |
| Shingo Tanaka | 132 | 156 | 454 | 74 | 62 | 1.0k | |
| Atsushi Nakano | 109 | 192 | 698 | 31 | 43 | 1.1k | |
| Harsh N. Shah | 145 | 200 | 490 | 71 | 26 | 1.2k | |
| Anne Gingery | 222 | 333 | 396 | 36 | 58 | 1.1k | |
| Fei Zheng | 93 | 318 | 383 | 57 | 39 | 928 | |
| Giovanna M. Crisi | 133 | 268 | 242 | 293 | 41 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...